[98] inhibited the TGF-β1-induced expression of EMT markers, indirectly demonstrating the effect of TGF-β1 on EMT and indicating that BHPF could be used as a possible novel therapy for endometrial cancer. This evidence concerns the gene TGFB1 and endometrial cancer.